NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients
Mechanical Ventilation Complication, Neuromuscular Electrical Stimulation, Muscle Weakness
About this trial
This is an interventional prevention trial for Mechanical Ventilation Complication focused on measuring Expiratory muscles, Mechanically ventilated patients, Neuromuscular electrical stimulation, Respiratory function, Ventilator-acquired muscle atrophy
Eligibility Criteria
Inclusion Criteria:
- age > 18 year
- invasive mechanical ventilation less than 72 hours
- expected duration of MV after inclusion > 72 hours
Exclusion Criteria:
- no clearly visible separate layers of the abdominal wall muscles (external oblique, internal oblique and transverse abdominal muscles), assessed with ultrasound during routine care
- cardiac pacemaker
- congenital myopathies and/or existing central or peripheral neuropathies
- refractory epilepsy
- recent abdominal surgery within four weeks prior to study inclusion
- body mass index (BMI) greater than 35 kg/m2
- pregnancy
Sites / Locations
- UMC NijmegenRecruiting
- Canisius Wilhelmina HospitalRecruiting
- VU University Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
VF03-K active stimulation
VF03-K sham stimulation
NMES applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.
Sham stimulation applied to the abdominal wall muscles using the VentFree prototype (VF03-K). Sham stimulation is applied twice daily for 30 minutes, 5 days per week, for 6 weeks or until the patient is weaned from mechanical ventilation, whichever occurs sooner.